Eversept Partners, LP

SEC CIK: 0001697013
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CLVS holding history

Clovis Oncology, Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLVS overview All 13F holders of CLVS Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2022

Holdings of CLVS by Eversept Partners, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−30,000−100.0%	Sold out	Holders
Q1 2022	30,000	$60.6K	<0.1%	+30,000	New	Holders